Cargando…
Acute side effects of radiation therapy : a guide to management /
This book provides clear guidance on how to manage a wide range of side effects frequently encountered when treating patients with radiation therapy. For each potential side effect, incidence, mechanism, symptoms, and grading are carefully described. All aspects of management are addressed, drawing...
| Clasificación: | Libro Electrónico |
|---|---|
| Autores principales: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer,
2017.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Foreword; Introduction; 1: Radiation Dermatitis; 1.1 Mechanism; 1.2 Timing; 1.3 Sign and Symptoms; 1.4 Scoring; 1.5 Risk Factors; 1.5.1 Treatment-Related Factors Including; 1.5.2 Patient-Related Factors Include; 1.6 Diagnosis; 1.7 Prevention; 1.7.1 General Measures; 1.7.2 Intensity-Modulated Radiation Therapy (IMRT); 1.7.3 Low-Level Laser Therapy; 1.7.4 Amifostine; 1.7.5 Ascorbic Acid; 1.7.6 Oral Zinc; 1.7.7 Silver Leaf Dressing; 1.7.8 MAS065D; 1.7.9 Soft Dressing or Barrier Film; 1.7.10 Hyaluronic Acid; 1.7.11 Trolamine; 1.7.12 Topical Sucralfate; 1.7.13 Theta Cream.
- 1.7.14 Dexpanthenol (Provitamin B5)1.7.15 Calendula; 1.7.16 Pentoxifylline; 1.7.17 Aloe Vera; 1.7.18 Deodorant; 1.7.19 Laughter Therapy; 1.8 Management; 1.8.1 Grade 1 Dermatitis; 1.8.2 Grade 2-3 Dermatitis; 1.8.3 Grade 4 Dermatitis; References; 2: Hair Loss; 2.1 Mechanism; 2.2 Timing; 2.2.1 Risk Factors; 2.2.2 Symptoms; 2.3 Scoring; 2.4 Prevention; 2.5 Management; References; 3: Radiation Brain Injury; 3.1 Mechanism; 3.2 Timing; 3.3 Risk Factors; 3.3.1 Treatment-Related Factors; 3.3.2 Patient-Related Factor; 3.4 Symptoms; 3.5 Diagnosis; 3.6 Scoring.
- 3.7 Prevention and Management3.7.1 Dexamethasone Prescription; References; 4: Radiation Orbital Toxicity; 4.1 Blepharitis and Eyelid Dermatitis; 4.2 Eyelash Loss; 4.3 Conjunctivitis; 4.4 Xerophthalmia; 4.5 Corneal Toxicity; 4.5.1 Treatment; 4.5.1.1 Topical Lubricants (e.g., Ophthalmic Ointment); 4.5.1.2 Analgesics; 4.5.1.3 Ophthalmologist Consult; 4.6 Iris Toxicity; References; 5: Ear Toxicity; 5.1 Mechanism; 5.2 Timing; 5.3 Risk Factors; 5.4 Symptoms and Diagnosis; 5.5 Scoring; 5.6 Management; References; 6: Oral Mucositis; 6.1 Mechanism; 6.2 Timing; 6.3 Risk Factors.
- 6.3.1 Tumor Site6.3.2 Concomitant Systemic Therapy; 6.3.3 Radiation Dose; 6.3.4 Radiation Fractionation Schedule; 6.3.5 Patient-Related Factors; 6.4 Symptoms; 6.5 Scoring; 6.6 Prevention; 6.6.1 Prophylactic Interventions; 6.6.2 Prophylactic Intervention Under Evaluation; 6.7 Management; 6.7.1 Patient Assessment; 6.7.2 Mouth Care; 6.7.3 Management of Oral Pain; 6.7.3.1 Benzydamine Mouth Wash; 6.7.3.2 Doxepin; 6.7.3.3 Magic Mouthwash; 6.7.3.4 Gelclair; 6.7.3.5 CAM2028; 6.7.3.6 MF 5232; 6.7.3.7 Acetylcysteine; 6.7.3.8 Opiates; 6.7.3.9 Corticosteroids; 6.7.3.10 Gabapentin.
- 6.7.3.11 Other Analgesic Agents6.7.3.12 Sucralfate; 6.7.3.13 Phenytoin Mouthwash; 6.7.3.14 Low-Level Laser Therapy; 6.7.4 Antifungals; 6.7.5 Antivirals; 6.7.6 Feeding Tube/Nutritional Support; References; 7: Xerostomia; 7.1 Mechanism; 7.2 Timing; 7.3 Risk Factors; 7.4 Symptoms; 7.5 Diagnosis; 7.6 Scoring; 7.7 Prevention; 7.7.1 Amifostin; 7.7.1.1 Prescription; 7.7.1.2 Contraindications; 7.7.1.3 Advers effects; 7.7.2 IMRT; 7.7.3 Submandibular gland transfer; 7.7.4 Pilocarpine; 7.7.4.1 Prescription; 7.7.4.2 Contraindications; 7.7.5 Acupuncture; 7.8 Management.